Operaciones Schrödinger, Inc. - SDGR CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.11 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024068% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.001846% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Cierre previo* | 25.48 |
Abrir* | 25.54 |
Cambio de 1 año* | -24.59% |
Rango del día* | 25.27 - 25.83 |
Rango de 52 semanas | 15.85-36.33 |
Volumen medio (10 días) | 535.22K |
Volumen medio (3 meses) | 11.92M |
Capitalización de mercado | 1.83B |
Ratio P/E | -100.00K |
Acciones en circulación | 80.65M |
Ingresos | 180.96M |
EPS | -2.10 |
Dividendo (Rendimiento %) | N/A |
Beta | -100.00K |
Próxima fecha de resultados | May 2, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Mar 24, 2023 | 25.48 | 0.52 | 2.08% | 24.96 | 25.75 | 24.91 |
Mar 23, 2023 | 25.46 | -0.56 | -2.15% | 26.02 | 26.82 | 24.78 |
Mar 22, 2023 | 25.85 | -0.49 | -1.86% | 26.34 | 27.24 | 25.18 |
Mar 21, 2023 | 26.70 | 1.38 | 5.45% | 25.32 | 27.02 | 25.14 |
Mar 20, 2023 | 25.23 | 0.18 | 0.72% | 25.05 | 25.69 | 24.47 |
Mar 17, 2023 | 25.43 | -0.24 | -0.93% | 25.67 | 26.54 | 24.89 |
Mar 16, 2023 | 26.51 | 1.35 | 5.37% | 25.16 | 26.72 | 25.07 |
Mar 15, 2023 | 25.55 | 1.08 | 4.41% | 24.47 | 25.74 | 24.29 |
Mar 14, 2023 | 25.48 | 0.76 | 3.07% | 24.72 | 25.64 | 24.43 |
Mar 13, 2023 | 24.30 | 1.39 | 6.07% | 22.91 | 24.39 | 22.19 |
Mar 10, 2023 | 23.32 | -1.20 | -4.89% | 24.52 | 24.74 | 22.54 |
Mar 9, 2023 | 24.78 | -0.40 | -1.59% | 25.18 | 25.68 | 24.50 |
Mar 8, 2023 | 25.30 | 0.24 | 0.96% | 25.06 | 25.65 | 24.70 |
Mar 7, 2023 | 25.14 | 0.23 | 0.92% | 24.91 | 25.88 | 24.33 |
Mar 6, 2023 | 24.98 | -1.31 | -4.98% | 26.29 | 26.29 | 24.87 |
Mar 3, 2023 | 26.03 | 1.78 | 7.34% | 24.25 | 26.22 | 23.31 |
Mar 2, 2023 | 24.27 | 0.31 | 1.29% | 23.96 | 25.64 | 23.74 |
Mar 1, 2023 | 24.58 | -1.02 | -3.98% | 25.60 | 27.04 | 24.41 |
Feb 28, 2023 | 21.63 | 0.45 | 2.12% | 21.18 | 21.84 | 21.02 |
Feb 27, 2023 | 21.42 | -0.33 | -1.52% | 21.75 | 21.82 | 21.07 |
Schrödinger, Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 180.955 | 137.931 | 108.095 | 85.543 | 66.639 |
Ingresos | 180.955 | 137.931 | 108.095 | 85.543 | 66.639 |
Coste de los ingresos, total | 79.933 | 72.311 | 44.623 | 36.45 | 23.702 |
Beneficio bruto | 101.022 | 65.62 | 63.472 | 49.093 | 42.937 |
Gastos totales de explotación | 327.772 | 249.374 | 169.011 | 124.258 | 94.608 |
Gastos de venta/general/administración Gastos, total | 121.467 | 86.159 | 59.693 | 46.291 | 34.259 |
Investigación y desarrollo | 126.372 | 90.904 | 64.695 | 38.786 | 34.215 |
Ingresos de explotación | -146.817 | -111.443 | -60.916 | -38.715 | -27.969 |
Ingresos por intereses (gastos), netos No operativos | -2.309 | 10.635 | 34.624 | 12.743 | -0.379 |
Ingresos netos antes de impuestos | -149.126 | -100.808 | -26.292 | -25.972 | -28.348 |
Ingresos netos después de impuestos | -149.189 | -101.219 | -26.637 | -25.681 | -28.425 |
Beneficio neto antes de partidas extra. Elementos | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Total de partidas extraordinarias | |||||
Ingresos netos | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Beneficio neto diluido | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Promedio ponderado de acciones diluidas | 71.1734 | 70.5949 | 60.0247 | 61.4472 | 61.4472 |
BPA diluido sin partidas extraordinarias | -2.09609 | -1.4221 | -0.40755 | -0.39987 | -0.46259 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
BPA normalizado diluido | -2.09609 | -1.4221 | -0.40755 | -0.39987 | -0.46259 |
Depreciation / Amortization | 2.731 | 2.432 | |||
Intereses menores | 0.003 | 0.826 | 2.174 | 1.11 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Ingresos totales | 56.843 | 36.98 | 38.469 | 48.663 | 46.17 |
Ingresos | 56.843 | 36.98 | 38.469 | 48.663 | 46.17 |
Coste de los ingresos, total | 18.139 | 19.779 | 21.335 | 20.68 | 19.809 |
Beneficio bruto | 38.704 | 17.201 | 17.134 | 27.983 | 26.361 |
Gastos totales de explotación | 85.381 | 83.143 | 81.942 | 77.306 | 68.685 |
Gastos de venta/general/administración Gastos, total | 32.7 | 30.479 | 29.484 | 28.804 | 23.731 |
Investigación y desarrollo | 34.542 | 32.885 | 31.123 | 27.822 | 25.145 |
Ingresos de explotación | -28.538 | -46.163 | -43.473 | -28.643 | -22.515 |
Ingresos por intereses (gastos), netos No operativos | 1.194 | 6.501 | -4.168 | -5.836 | -7.926 |
Ingresos netos antes de impuestos | -27.344 | -39.662 | -47.641 | -34.479 | -30.441 |
Ingresos netos después de impuestos | -27.208 | -39.856 | -47.674 | -34.451 | -30.715 |
Intereses menores | 0.001 | 0.003 | -0.012 | 0.011 | 0.002 |
Beneficio neto antes de partidas extra. Elementos | -27.207 | -39.853 | -47.686 | -34.44 | -30.713 |
Ingresos netos | -27.207 | -39.853 | -47.686 | -34.44 | -30.713 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -27.207 | -39.853 | -47.686 | -34.44 | -30.713 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -27.207 | -39.853 | -47.686 | -34.44 | -30.713 |
Beneficio neto diluido | -27.207 | -39.853 | -47.686 | -34.44 | -30.713 |
Promedio ponderado de acciones diluidas | 71.2716 | 71.208 | 71.1619 | 71.0504 | 70.9341 |
BPA diluido sin partidas extraordinarias | -0.38174 | -0.55967 | -0.67011 | -0.48473 | -0.43298 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
BPA normalizado diluido | -0.38174 | -0.55967 | -0.67011 | -0.48473 | -0.43298 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Activo Corriente | 625.06 | 682.978 | 118.536 | 104.69 | 48.054 |
Efectivo e inversiones a corto plazo | 576.479 | 642.691 | 85.83 | 84.067 | 36.343 |
Efectivo y Equivalentes | 120.267 | 202.296 | 25.986 | 77.716 | 9.96 |
Inversiones a corto plazo | 456.212 | 440.395 | 59.844 | 6.351 | 26.383 |
Total deudores, neto | 40.551 | 35.378 | 25.738 | 18.021 | 9.759 |
Accounts Receivable - Trade, Net | 40.015 | 35.012 | 25.58 | 17.995 | 9.759 |
Prepaid Expenses | 5.03 | 4.409 | 6.468 | 2.602 | 1.952 |
Total Assets | 756.487 | 746.263 | 155.27 | 120.73 | 58.022 |
Property/Plant/Equipment, Total - Net | 85.409 | 15.269 | 19.03 | 7.967 | 5.439 |
Property/Plant/Equipment, Total - Gross | 97.764 | 29.071 | 29.592 | 17.4 | 14.677 |
Accumulated Depreciation, Total | -12.355 | -13.802 | -10.562 | -9.433 | -9.238 |
Intangibles, Net | 0 | 0.015 | 0.052 | ||
Long Term Investments | 43.167 | 45.664 | 15.366 | 5.444 | 2.609 |
Other Long Term Assets, Total | 2.851 | 2.352 | 2.338 | 2.614 | 1.868 |
Total Current Liabilities | 91.211 | 73.205 | 45.02 | 27.005 | 17.818 |
Accounts Payable | 8.079 | 8.398 | 3.524 | 2.773 | 1.61 |
Accrued Expenses | 27.764 | 19.404 | 16.442 | 6.587 | 5.052 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 55.368 | 45.403 | 25.054 | 17.645 | 11.156 |
Total Liabilities | 199.416 | 122.248 | 57.054 | 30.603 | 21.074 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 108.191 | 49.039 | 11.993 | 3.598 | 3.256 |
Total Equity | 557.071 | 624.015 | 98.216 | 90.127 | 36.948 |
Preferred Stock - Non Redeemable, Net | 0 | 191.58 | 161.687 | 82.31 | |
Common Stock | 0.71 | 0.699 | 0.061 | 0.059 | 0.055 |
Additional Paid-In Capital | 786.964 | 752.558 | 11.655 | 8.915 | 6.71 |
Retained Earnings (Accumulated Deficit) | -229.952 | -129.559 | -105.096 | -80.525 | -52.1 |
Other Equity, Total | -0.651 | 0.317 | 0.016 | -0.009 | -0.027 |
Total Liabilities & Shareholders’ Equity | 756.487 | 746.263 | 155.27 | 120.73 | 58.022 |
Total Common Shares Outstanding | 70.9987 | 69.8777 | 61.4472 | 61.4472 | 61.4472 |
Other Current Assets, Total | 3 | 0.5 | 0.5 | ||
Minority Interest | 0.014 | 0.004 | 0.041 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Activo Corriente | 586.168 | 625.06 | 622.025 | 649.788 | 675.238 |
Efectivo e inversiones a corto plazo | 525.532 | 576.479 | 597.186 | 613.591 | 648.494 |
Efectivo y Equivalentes | 117.257 | 120.267 | 160.879 | 117.699 | 133.122 |
Inversiones a corto plazo | 408.275 | 456.212 | 436.307 | 495.892 | 515.372 |
Total deudores, neto | 45.594 | 40.551 | 16.33 | 25.904 | 18.29 |
Accounts Receivable - Trade, Net | 44.086 | 40.015 | 16.347 | 25.953 | 17.974 |
Prepaid Expenses | 11.542 | 5.03 | 5.509 | 7.293 | 7.954 |
Other Current Assets, Total | 3.5 | 3 | 3 | 3 | 0.5 |
Total Assets | 719.537 | 756.487 | 762.617 | 717.334 | 744.189 |
Property/Plant/Equipment, Total - Net | 89.256 | 85.409 | 85.533 | 14.451 | 13.664 |
Long Term Investments | 37.002 | 43.167 | 51.087 | 49.713 | 52.931 |
Other Long Term Assets, Total | 1.334 | 2.851 | 3.972 | 3.382 | 2.356 |
Total Current Liabilities | 85.532 | 91.211 | 72.916 | 70.378 | 67.621 |
Accounts Payable | 9.766 | 8.079 | 8.228 | 5.96 | 7.22 |
Accrued Expenses | 21.995 | 27.764 | 20.814 | 20.349 | 19.642 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 53.771 | 55.368 | 43.874 | 44.069 | 40.759 |
Total Liabilities | 188.87 | 199.416 | 182.811 | 111.583 | 112.421 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0.003 | 0.014 | 0.016 | 0.02 | 0.008 |
Other Liabilities, Total | 103.335 | 108.191 | 109.879 | 41.185 | 44.792 |
Total Equity | 530.667 | 557.071 | 579.806 | 605.751 | 631.768 |
Common Stock | 0.712 | 0.71 | 0.709 | 0.708 | 0.705 |
Additional Paid-In Capital | 797.004 | 786.964 | 778.292 | 769.199 | 760.574 |
Retained Earnings (Accumulated Deficit) | -264.392 | -229.952 | -199.239 | -164.232 | -129.588 |
Other Equity, Total | -2.657 | -0.651 | 0.044 | 0.076 | 0.077 |
Total Liabilities & Shareholders’ Equity | 719.537 | 756.487 | 762.617 | 717.334 | 744.189 |
Total Common Shares Outstanding | 71.1366 | 70.9987 | 70.8676 | 70.7178 | 70.4649 |
Goodwill, Net | 4.791 | ||||
Intangibles, Net | 0.986 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -101.219 | -26.637 | -25.681 | -28.425 | -17.392 |
Efectivo de actividades de explotación | -70.669 | 16.757 | -26.059 | -23.711 | -15.307 |
Efectivo de actividades de explotación | 2.847 | 3.658 | 3.64 | 2.894 | 1.685 |
Partidas no monetarias | 23.026 | -19.44 | -8.313 | 1.539 | -1.188 |
Cash Taxes Paid | 0.448 | 0.381 | 0.139 | 0.013 | 0.348 |
Cambios en el capital circulante | 4.677 | 59.176 | 4.295 | 0.281 | 1.588 |
Efectivo de actividades de inversión | -16.812 | -381.721 | -53.855 | 11.194 | 2.049 |
Gastos de capital | -7.167 | -2.538 | -1.836 | -5.259 | -3.7 |
Otras partidas de flujo de caja de inversión, total | -9.645 | -379.183 | -52.019 | 16.453 | 5.749 |
Efectivo procedente de actividades de financiación | 7.952 | 541.274 | 28.684 | 80.273 | 1.129 |
Emisión (retiro) de acciones, neto | 7.927 | 541.274 | 30.442 | 80.273 | 1.129 |
Variación neta de la tesorería | -79.529 | 176.31 | -51.23 | 67.756 | -12.129 |
Elementos de flujo de caja de financiación | 0.025 | 0 | -1.758 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -34.451 | -101.219 | -70.504 | -35.493 | -0.523 |
Cash From Operating Activities | -39.722 | -70.669 | -50.931 | -40.293 | -10.921 |
Cash From Operating Activities | 0.969 | 2.847 | 2.195 | 1.614 | 0.887 |
Non-Cash Items | 16.798 | 23.026 | 7.164 | -3.581 | -16.21 |
Cash Taxes Paid | 0.037 | 0.448 | 0.236 | 0.224 | 0.119 |
Changes in Working Capital | -23.038 | 4.677 | 10.214 | -2.833 | 4.925 |
Cash From Investing Activities | 36.304 | -16.812 | 5.279 | -47.097 | -61.909 |
Capital Expenditures | -1.696 | -7.167 | -6.21 | -3.427 | -0.513 |
Other Investing Cash Flow Items, Total | 38 | -9.645 | 11.489 | -43.67 | -61.396 |
Cash From Financing Activities | 0.908 | 7.952 | 6.735 | 5.293 | 3.656 |
Issuance (Retirement) of Stock, Net | 0.908 | 7.927 | 6.71 | 5.268 | 3.656 |
Net Change in Cash | -2.51 | -79.529 | -38.917 | -82.097 | -69.174 |
Financing Cash Flow Items | 0.025 | 0.025 | 0.025 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Bill & Melinda Gates Foundation Trust | Endowment Fund | 11.2027 | 6981664 | 0 | 2022-12-31 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.1958 | 5107748 | 63870 | 2022-12-31 | LOW |
ARK Investment Management LLC | Investment Advisor | 6.1809 | 3852037 | 87330 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.5071 | 3432108 | 214844 | 2022-12-31 | LOW |
Credit Suisse Asset Management | Investment Advisor/Hedge Fund | 4.158 | 2591296 | 349109 | 2022-12-31 | LOW |
Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 4.0185 | 2504407 | 94630 | 2022-12-31 | LOW |
Schrodinger Equity Holdings LLC | Corporation | 3.847 | 2397513 | -7260829 | 2021-12-01 | |
Baillie Gifford & Co. | Investment Advisor | 2.9233 | 1821858 | 640051 | 2022-12-31 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 2.2808 | 1421435 | 1421435 | 2022-12-31 | HIGH |
Friesner (Richard A) | Individual Investor | 1.97 | 1227703 | 0 | 2022-04-19 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.8294 | 1140112 | 79505 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.618 | 1008367 | 24525 | 2022-12-31 | LOW |
Rubric Capital Management LP | Hedge Fund | 1.6046 | 1000000 | -77621 | 2022-12-31 | MED |
Stephens Investment Management Group, LLC | Investment Advisor | 1.2511 | 779715 | 3183 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.1777 | 733941 | 195764 | 2022-12-31 | LOW |
ACATIS Investment Kapitalverwaltungsgesellschaft GmbH | Investment Advisor | 1.1686 | 728300 | 0 | 2023-01-31 | LOW |
Invus Public Equities Advisors, LLC | Investment Advisor | 1.1232 | 700000 | 0 | 2022-12-31 | LOW |
Tocqueville Asset Management LP | Investment Advisor/Hedge Fund | 1.0707 | 667285 | 296005 | 2022-12-31 | LOW |
Pertento Partners LLP | Investment Advisor | 1.0213 | 636507 | 32824 | 2022-12-31 | MED |
Baron Capital Management, Inc. | Investment Advisor/Hedge Fund | 0.9941 | 619545 | -88259 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Schrödinger, Inc. Company profile
Sobre Schrodinger Inc
Schrodinger, Inc. ha desarrollado una plataforma de software basada en la física, que permite descubrir moléculas para el desarrollo de fármacos y aplicaciones de materiales. La plataforma de software es utilizada por empresas biofarmacéuticas e industriales, instituciones académicas y laboratorios gubernamentales de todo el mundo. La empresa también aprovecha su plataforma de software para avanzar en programas de colaboración y en su propia cartera de productos terapéuticos para satisfacer necesidades médicas no cubiertas. La empresa opera a través de dos segmentos: software y descubrimiento de fármacos. El segmento de software se centra en la venta de su software para transformar el descubrimiento de fármacos en la industria de las ciencias de la vida, así como a los clientes en las industrias de ciencias de los materiales. El segmento de descubrimiento de fármacos se centra en la construcción de una cartera de programas preclínicos y clínicos, internamente y a través de colaboraciones, que ha avanzado a varias etapas de descubrimiento y desarrollo. La cartera de programas de descubrimiento de fármacos de la empresa incluye MALT1, CDC7, Wee1 y SOS1/KRAS.
Industry: | Software (NEC) |
1540 Broadway
24Th Floor
NEW YORK
NEW YORK 10036
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com